Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct;20(10):102909.
doi: 10.1016/j.autrev.2021.102909. Epub 2021 Jul 16.

The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19

Affiliations
Comment

The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19

Elrashdy M Redwan et al. Autoimmun Rev. 2021 Oct.
No abstract available

Keywords: Autoimmune disease; Autoimmune response; Autoimmunity disorders; COVID-19; Rheumatoid arthritis; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

There are no competing interests for any author.

Figures

Fig. 1
Fig. 1
The suggested scenarios behind how SARS-CoV-2 triggers autoimmune diseases. 1: Healthy 2: Infected 3: Moderate Damage (Accumulating fluid, reduced gas exchange) 4: Severe damage (Build-up of protein-rich fluid, very limited gas exchange), during moderate to severe (3-4) many cells type expects to damaged releasing their enzymatic molecules which may work on several extracellular matrices proteome creating neo-autoantigen which subsequently elicit the autoimmune response associate with the SARS-CoV-2 infection.

Comment on

References

    1. Perrot L., Hemon M., Busnel J.M., Muis-Pistor O., Picard C., Zandotti C., et al. First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021;3:e6–e8. - PMC - PubMed
    1. Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Liu F., et al. 2020. Diverse Functional Autoantibodies in Patients with COVID-19, medRxiv : the preprint server for health sciences.
    1. Halpert G., Shoenfeld Y. SARS-CoV-2, the autoimmune virus. Autoimmun. Rev. 2020;19:102695. - PMC - PubMed
    1. Hasseli R., Mueller-Ladner U., Schmeiser T., Hoyer B.F., Krause A., Lorenz H.M., et al. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. RMD open. 2020;6 - PMC - PubMed
    1. Barzilai O., Ram M., Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr. Opin. Rheumatol. 2007;19:636–643. - PubMed